Emory, Balloon Angioplasty, and the Musk Attack on Medical Diplomacy

By MIKE MAGEE  “The recently announced limitation from the NIH on grants is an example that will significantly reduce essential funding for research at Emory.”                                                      Gregory L. Fenes, President, Emory University  In 1900, the U.S. life expectancy was 47 years. Between maternal deaths in child birth and infectious disease, it is no wonder that…

Read More

DOGE Job Cuts Hit Federal Workers’ Finances and Mental Health

LISTEN: KFF Health News correspondent Rachana Pradhan spoke with federal employees who say mass government layoffs are affecting their mental health. She appeared on WAMU’s “Health Hub” segment on April 2. Federal workers are feeling demoralized and anxious as the Department of Government Efficiency slashes tens of thousands of jobs. Federal employment used to carry…

Read More

Impact of Medicare Part B on pharmaceutical price growth

Does Medicare Part B increase or decrease the prices of physician-administered drugs relative to physician-administered drugs covered by private insurance? That is the question a paper by Acquatella, Ericson and Starc (2023) aim to answer. Before we answer that question, we first need to understand how Part B works, how physicians are reimbursed, and how…

Read More

Takeda Vows Appeal of $885M Jury Verdict in ‘Pay-for-Delay’ Antitrust Case

Pharmacies and wholesalers claimed Takeda Pharmaceutical delayed generic competition from entering the market, forcing them to overpay for a gastrointestinal drug. Takeda said the trial had “evidentiary and legal errors,” and the company will appeal the verdict. The post Takeda Vows Appeal of $885M Jury Verdict in ‘Pay-for-Delay’ Antitrust Case appeared first on MedCity News.

Read More